Khorana Score: A Potential New Biomarker for Real Life Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Immunotherapy

被引：0
|
作者：
Bjornhart, B. [1 ]
Hansen, K. [2 ]
Jorgensen, T. [3 ]
Herrstedt, J. [4 ]
Schytte, T. [1 ]
机构：
[1] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
[2] Odense Univ Hosp, Oncol, Odense C, Denmark
[3] Acad Geriatr Canc Res Agecare, Clin Oncol, Odense, Denmark
[4] Zealand Univ Hosp, Clin Oncol, Roskilde, Denmark
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Biomarker; Non small cell lung cancer; Checkpoint inhibitors;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP1.04-29
引用
收藏
页码：S980 / S981
页数：2
相关论文
共 50 条
  • [41] The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
    Brahmer, Julie R.
    Govindan, Ramaswamy
    Anders, Robert A.
    Antonia, Scott J.
    Sagorsky, Sarah
    Davies, Marianne J.
    Dubinett, Steven M.
    Ferris, Andrea
    Gandhi, Leena
    Garon, Edward B.
    Hellmann, Matthew D.
    Hirsch, Fred R.
    Malik, Shakuntala
    Neal, Joel W.
    Papadimitrakopoulou, Vassiliki A.
    Rimm, David L.
    Schwartz, Lawrence H.
    Sepesi, Boris
    Yeap, Beow Yong
    Rizvi, Naiyer A.
    Herbst, Roy S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [42] Evaluation of Combined Biomarker of Response to Immunotherapy in Patients with Advanced Non-Small Cell Lung Cancer
    Ramdani, H.
    Falk, M.
    Schatz, S.
    Heukamp, L.
    Tiemann, M.
    Wesseler, C.
    Schuuring, E.
    Groen, H.
    Griesinger, F.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S413 - S414
  • [43] New strategies in immunotherapy for non-small cell lung cancer
    Carrizosa, Daniel R.
    Gold, Kathryn A.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (05) : 553 - 559
  • [44] New advances in immunotherapy for non-small cell lung cancer
    Qin, Haifeng
    Wang, Fang
    Liu, Hui
    Zeng, Zhen
    Wang, Shasha
    Pan, Xin
    Gao, Hongjun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (08): : 2234 - 2245
  • [45] Molecular Characterization by Next-Generation Sequencing (NGS) of Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Immunotherapy
    Cruz Castellanos, P.
    Rosas Alonso, R.
    Ozaez, I.
    Hernandez, I.
    Losantos, I.
    Gutierrez Sainz, L.
    Higuera Gomez, O.
    Rodriguez Antolin, C.
    Esteban Rodriguez, I.
    Ibanez de Caceres, I.
    de Castro Carpeno, J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S558 - S558
  • [46] Neoadjuvant Immunotherapy for Patients with non-small cell Lung Cancer
    Luecke, E.
    Ganzert, C.
    Waesche, A.
    Walles, T.
    Schreiber, J.
    PNEUMOLOGIE, 2020, 74 : S74 - S75
  • [47] Performance status, survival, and end-of-life care in adults with non-small cell lung cancer (NSCLC) treated with immunotherapy.
    Petrillo, Laura A.
    El-Jawahri, Areej
    Nipp, Ryan David
    Lichtenstein, Morgan
    Reynolds, Kerry Lynn
    Greer, Joseph
    Temel, Jennifer S.
    Gainor, Justin F.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (31)
  • [48] Adjuvant Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Preoperative Chemotherapy
    Deng, L.
    Jiang, C.
    Perimbeti, S.
    Chen, H.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S234 - S234
  • [49] RISK OF KIDNEY FAILURE IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC) TREATED WITH PEMETREXED
    Kongsted, P.
    Mellemgaard, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 444 - 444
  • [50] Radiomic analysis of non-small cell lung cancer (NSCLC) patients treated with radical radiotherapy
    Hindocha, S.
    Orton, M.
    Doran, S.
    Philipps, L.
    Koh, D-M
    Blackledge, M.
    Lee, R.
    LUNG CANCER, 2020, 139 : S41 - S41
12345